Ding Meng | China Business Law Journal



Home Tags Posts tagged with "Ding Meng"

Tag: Ding Meng

Quintet aids InnoScience’s HKD1.4bn debut in Hong Kong

Five law firms have advised semiconductor manufacturer InnoScience Technology’s HKD1.4 billion IPO on the HKEX

Slow start for Chapter 18C as QuantumPharm debuts on HKEX

Tencent-backed AI drug researcher QuantumPharm has finally debuted on the HKEX as the first IPO via the new regulations

Jianzhi Education first Chinese VIE to debut on Nasdaq since DiDi crackdown

Jianzhi Education Technology Group is the first Chinese variable interest entity (VIE) to debut on the Nasdaq since DiDi’s 2021 listing on the same market sparked a crackdown by Chinese authorities

Five firms steer MINISO’s dual-primary listing in Hong Kong

Global retailer MINISO Group has achieved its dual-primary listing on the Hong Kong bourse, raising USD72.2 million. Five law firms assisted in the listing

Mega Genomics raises HKD215.3m on debut

China’s largest consumer genetic testing platform Mega Genomics raised HKD215.3 million (USD27.6 million) from its IPO on the HKEX

LATEST ON LAW.ASIA

[TEST] EXTEND CACHE DEV

Korea Law Firm Awards

[TEST] Extend Cache

Laws and regulations on private equity funds in Japan

By Yuki Sato, Chiho Saito and Taiki Hashimoto, So & Sato Law Offices

Navigating legality and validity of non-competes

By Zhu Tao and Guo Zhiyan, ETR Law Firm

MOST READ ON LAW.ASIA

Correspondents

Delhi High Court anti-arbitration injunction Singapore

India to be an outlier in dispute resolution

By Sneha Jaisingh and Rasika Alur, Bharucha & Partners
Strategic investor definition for REITs and InvITsvideo

Reforms widen REITs and InvITs investor base

By Parag Bhide, Bharucha & Partners
Reasonable Criteria For Tax Deductibility In Philippines

Reasonable criteria for tax deductibility in Philippines

By Jacqueline Ann A Tan, ACCRALAW
Foreign direct investment in India’s hospital sector

Hospitals in India a healthy investment opportunity

By Anand Jayachandran and Aditya Prasad, Cyril Amarchand Mangaldas

Follow us on LinkedIn

Follow now